Clinical and demographic characteristics of patients with psoriatic arthritis in northern Israel

Rheumatology International

Volumn 32, Issue 3, 2012, Pages 595-600

  Zisman, Devy ^a,b   Eder, Lihi ^a,b   Elias, Muna ^b   Laor, Arie ^a   Bitterman, Haim ^a,d   Rozenbaum, Michael ^c   Feld, Joy ^c   Rimar, Doron ^c   Rosner, Itzhak ^c,d  

^a CARMEL MEDICAL CENTER   (Israel)

^b CLALIT HEALTH SERVICES   (Israel)

^c BNAI ZION MEDICAL CENTER   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Characteristics; Psoriasis; Psoriatic arthritis

Indexed keywords

AZATHIOPRINE; COLCHICINE; CYCLOSPORIN; GOLD SALT; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR INHIBITOR; ANTIRHEUMATIC AGENT; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BONE EROSION; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DACTYLITIS; DEMOGRAPHY; DIABETES MELLITUS; DISEASE DURATION; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISRAEL; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NAIL; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RADIODIAGNOSIS; SEX DIFFERENCE; CLINICAL CHEMISTRY; DRUG COMBINATION; FAMILY HEALTH; JOINT; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY;

ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; CLINICAL CHEMISTRY TESTS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; DIABETES MELLITUS; DRUG THERAPY, COMBINATION; FAMILY HEALTH; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; ISRAEL; JOINTS; MALE; METHOTREXATE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84863317280     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1673-1     Document Type: Article

References (28)

1. Brockbank J, Gladman DD (2002) Diagnosis and management of psoriatic arthritis. Drugs 62:2447-2457 (Pubitemid 35448135)
2. Brockbank J, Gladman DD (2002) Diagnosis and management of psoriatic arthritis. Drugs 62:2447-2457 (Pubitemid 35448135)
3. Taylor W, Gladman DD, Helliwell P et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665-2673 (Pubitemid 44205029)
4. Zachariae H (2003) Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol 4:441-447 (Pubitemid 36871763)
5. Gladman DD, Shuckett R, Russell ML et al (1987) Psoriatic arthritis. An analysis of 220 patients. Q J Med 62:127-141 (Pubitemid 17042878)
6. Jones SM, Armas JB, Cohen MG, Lovell CR, Evison G, McHugh NJ (1994) Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 33:834-839 (Pubitemid 24283222)
7. Moll JMH, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3:55-78
8. Khan M, Schentag C, Gladman DD (2003) Clinical and radiological changes during psoriatic arthritis disease progression. J Rheumatol 30:1022-1026 (Pubitemid 36529624)
9. Veale D, Rogers S, Fitzgerald O (1994) Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol 33:133-138 (Pubitemid 24051604)
10. Cuellar ML, Citera G, Espinoza LR (1994) Treatment of psoriatic arthritis. Baillieres Clin Rheumatol 8:483-498 (Pubitemid 24189851)
11. Abu-Shakra M, Gladman DD, Thorne CT et al (1995) Long term methotrexate therapy in psoriatic arthritis: clinical and radiologic outcome. J Rheumatol 22:241-245
12. Gupta AK, Grober JS, Hamilton TA et al (1995) Sulfasalazine therapy for psoriatic arthritis: a double blind, placebo controlled trial. J Rheumatol 22:894-898
13. Kaltwasser JP, Nash P, Gladman D et al (2004) Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebocontrolled clinical trial. Arthritis Rheum 50:1939-1950 (Pubitemid 38725106)
14. Salvarani C, Maccioni P, Olivieri I et al (2001) A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis. J Rheumatol 28:2274-2282 (Pubitemid 32947875)
15. Mease PJ, Goffe BS, Metz J et al (2000) Etanercept in the treatment of psoriatic arthritis and psoriasis: A randomized trial. Lancet 356:385-390 (Pubitemid 30487495)
16. Salvarani C, Cantini F, Olivieri I et al (2003) Efficacy of infliximab in resistant psoriatic arthritis. Arthritis Rheum 49:541-545 (Pubitemid 36988308)
17. Torre Alonso JC, Rodriguez Perez A, Arribas Castrillo JM et al (1991) Psoriatic arthritis: a clinical, immunological and radiological study of 180 patients. British J Rheumatol 30:245-250
18. Rajendran JP, Ledge SG, Rani K et al (2003) Psoriatic arthritis. J Assoc Physicians India 51:1065-1068 (Pubitemid 41279815)
19. Madland TM, Apalset EM, Johannessen AE, Rossebo B, Brun JG (2005) Prevalence, disease manifestations and treatment of psoriatic arthritis in western Norway. J Rheumatol 32:1918-1922 (Pubitemid 41429022)
20. Punzi L, Pianon M, Rossini P et al (1999) Clinical and laboratory manifestations of elderly onset psoriatic arthritis: a comparison with younger onset disease. Ann Rheum Dis 58:226-229 (Pubitemid 29191653)
21. Williamson L, Dalbeth N, Dockerty JL et al (2004) Extended report: Nail disease in psoriatic arthritis-clinically important, potentially treatable and often overlooked. Rheumtology (Oxford) 43:690-691
22. Sampaio-Barros PD, Conde RA, Bonfiglioli R et al (2006) Characterization of outcome of uveitis in 350 patients with spondyloarthropathies. Rheumatol Int 26:1143-1146 (Pubitemid 44450852)
23. Soriano ER, McHugh NJ (2006) Therapies for peripheral joint disease in psoriatic arthritis. A systematic review. J Rheumatol 33:1422-1430 (Pubitemid 44025163)
24. Jones G, Crotty M, Brooks P (2000) Interventions for psoriatic arthritis. Cochrane Database Syst Rev 3:CD000212
25. Kimhi O, Caspi D, Bornstein NM et al (2007) Prevalence and risk factors for atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum 36:203-209 (Pubitemid 46188476)
26. Han C, Robinson DW Jr, Hackett MV et al (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. J Rheumatol 33:2167-2172 (Pubitemid 44749774)
27. Eder L, Zisman D, Barzilai M, Laor A, Rahat M, Rozenbaum M, Bitterman H, Feld J, Rimar D, Rosner I (2008) Subclinical atherosclerosis in psoriatic arthritis: a case-control study. J Rheumatol 35:877-882 (Pubitemid 351747131)
28. Rennert G, Peterburg Y (2001) Prevalence of selected chronic diseases in Israel. Isr Med Assoc J 3:404-408 (Pubitemid 34176916)